The study started after the second COVID-19 vaccination of the participant with blood spots appearing on the skin with severe arthritis. The study continued to the third-dose full vaccination of the participant with the recombined COVID-19 vaccination and afterwards. The study completed until intervention.
Age range
18 Years – 70 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Chemiluminescent Immunoassay for Human Immunodeficiency Virus
Timeframe: 7 months
Carcinoembryonic Antigen
Timeframe: 7 months
Alpha Fetoprotein
Timeframe: 7 months
Carbohydrate Antigen 19-9
Timeframe: 7 months
Mucin-16
Timeframe: 7 months
Cancer Antigen 15-3
Timeframe: 7 months
Prostate-Specific Antigen
Timeframe: 7 months
Leukocytes
Timeframe: 7 months
Leukocyte Percentage
Timeframe: 7 months
Cholesterol
Timeframe: 7 months